Sana Biotechnology, Inc. (SANA)
3.92
+0.03
(+0.77%)
USD |
NASDAQ |
Sep 03, 11:20
Sana Biotechnology Research and Development Expense (TTM) : 129.50M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 129.50M |
| March 31, 2026 | 124.29M |
| December 31, 2025 | 133.90M |
| September 30, 2025 | 127.30M |
| June 30, 2025 | 138.70M |
| March 31, 2025 | 144.13M |
| December 31, 2024 | 199.57M |
| September 30, 2024 | 217.33M |
| June 30, 2024 | 215.49M |
| March 31, 2024 | 243.97M |
| December 31, 2023 | 213.97M |
| Date | Value |
|---|---|
| September 30, 2023 | 206.94M |
| June 30, 2023 | 234.71M |
| March 31, 2023 | 238.50M |
| December 31, 2022 | 239.65M |
| September 30, 2022 | 248.63M |
| June 30, 2022 | 227.89M |
| March 31, 2022 | 200.27M |
| December 31, 2021 | 176.98M |
| September 30, 2021 | 159.23M |
| June 30, 2021 | 134.58M |
| March 31, 2021 | 122.17M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 71.86M |
| Beam Therapeutics, Inc. | 408.66M |
| Prime Medicine, Inc. | 146.20M |
| Intellia Therapeutics, Inc. | 337.63M |
| Moderna, Inc. | 2.635B |